Nuvation Bio (NUVB) Shares Issued: 2020-2025

Historic Shares Issued for Nuvation Bio (NUVB) over the last 2 years, with Jun 2025 value amounting to $762,000.

  • Nuvation Bio's Shares Issued fell 60.46% to $762,000 in Q2 2025 from the same period last year, while for Jun 2025 it was $4.4 million, marking a year-over-year increase of 87.43%. This contributed to the annual value of $4.5 million for FY2024, which is 1088.80% up from last year.
  • Nuvation Bio's Shares Issued amounted to $762,000 in Q2 2025, which was down 29.57% from $1.1 million recorded in Q1 2025.
  • In the past 5 years, Nuvation Bio's Shares Issued registered a high of $1.9 million during Q2 2024, and its lowest value of -$3.8 million during Q1 2021.
  • Moreover, its 3-year median value for Shares Issued was $801,000 (2024), whereas its average is $834,625.
  • As far as peak fluctuations go, Nuvation Bio's Shares Issued tumbled by 92.95% in 2024, and later spiked by 5,052.38% in 2025.
  • Quarterly analysis of 5 years shows Nuvation Bio's Shares Issued stood at -$3.8 million in 2021, then surged by 108.29% to $311,000 in 2022, then plummeted by 70.16% to $77,000 in 2023, then skyrocketed by 2,068.83% to $840,000 in 2024, then slumped by 60.46% to $762,000 in 2025.
  • Its Shares Issued stands at $762,000 for Q2 2025, versus $1.1 million for Q1 2025 and $840,000 for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Summit Therapeutics Inc. 1,387.71B 1,387.50B -
2 BeOne Medicines Ltd. 458.68B 457.16B 1.15B
3 Vertex Pharmaceuticals Inc / Ma 102.37B 99.35B -
4 Benitec Biopharma Inc. 65.38B 65.31B -
5 Regeneron Pharmaceuticals, Inc. 60.67B 60.28B -
6 Alnylam Pharmaceuticals, Inc. 60.53B 62.66B -
7 Argenx Se 45.96B 50.00B -
8 INSMED Inc 26.50B 27.40B -
9 BioNTech SE 25.15B 17.24B -
10 Nuvation Bio Inc. 1.42B 1.38B 2.26M

Historic Data

Download Data 🔒
Date Value
Sep 30, 2025 558,000
Sep 30, 2025 558,000
Jun 30, 2025 762,000
Jun 30, 2025 762,000
Mar 31, 2025 1.08M
Mar 31, 2025 1.08M
Dec 31, 2024 840,000
Dec 31, 2024 840,000
Sep 30, 2024 1.67M
Sep 30, 2024 1.67M
Jun 30, 2024 1.93M
Jun 30, 2024 1.93M